Cargando…
P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM]
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431342/ http://dx.doi.org/10.1097/01.HS9.0000847068.32650.9b |
| _version_ | 1784780028444147712 |
|---|---|
| author | Vannucchi, A. Mesa, R. Gerds, A. Al-Ali, H. K. Lavie, D. Kuykendall, A. Grosicki, S. Iurlo, A. Goh, Y. T. Lazaroiu, M. Egyed, M. Fox, M. L. McLornan, D. Perkins, A. Yoon, S.-S. Gupta, V. Kiladjian, J.-J. Donahue, R. Kawashima, J. Verstovsek, S. |
| author_facet | Vannucchi, A. Mesa, R. Gerds, A. Al-Ali, H. K. Lavie, D. Kuykendall, A. Grosicki, S. Iurlo, A. Goh, Y. T. Lazaroiu, M. Egyed, M. Fox, M. L. McLornan, D. Perkins, A. Yoon, S.-S. Gupta, V. Kiladjian, J.-J. Donahue, R. Kawashima, J. Verstovsek, S. |
| author_sort | Vannucchi, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431342 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313422022-08-31 P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] Vannucchi, A. Mesa, R. Gerds, A. Al-Ali, H. K. Lavie, D. Kuykendall, A. Grosicki, S. Iurlo, A. Goh, Y. T. Lazaroiu, M. Egyed, M. Fox, M. L. McLornan, D. Perkins, A. Yoon, S.-S. Gupta, V. Kiladjian, J.-J. Donahue, R. Kawashima, J. Verstovsek, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431342/ http://dx.doi.org/10.1097/01.HS9.0000847068.32650.9b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Vannucchi, A. Mesa, R. Gerds, A. Al-Ali, H. K. Lavie, D. Kuykendall, A. Grosicki, S. Iurlo, A. Goh, Y. T. Lazaroiu, M. Egyed, M. Fox, M. L. McLornan, D. Perkins, A. Yoon, S.-S. Gupta, V. Kiladjian, J.-J. Donahue, R. Kawashima, J. Verstovsek, S. P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] |
| title | P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] |
| title_full | P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] |
| title_fullStr | P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] |
| title_full_unstemmed | P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] |
| title_short | P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] |
| title_sort | p1050: thrombocytopenic myelofibrosis (mf) patients previously treated with a jak inhibitor in a phase 3 randomized study of momelotinib (mmb) versus danazol (dan) [momentum] |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431342/ http://dx.doi.org/10.1097/01.HS9.0000847068.32650.9b |
| work_keys_str_mv | AT vannucchia p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT mesar p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT gerdsa p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT alalihk p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT lavied p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT kuykendalla p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT grosickis p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT iurloa p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT gohyt p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT lazaroium p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT egyedm p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT foxml p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT mclornand p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT perkinsa p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT yoonss p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT guptav p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT kiladjianjj p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT donahuer p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT kawashimaj p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum AT verstovseks p1050thrombocytopenicmyelofibrosismfpatientspreviouslytreatedwithajakinhibitorinaphase3randomizedstudyofmomelotinibmmbversusdanazoldanmomentum |